Ruben A. Bartolomé

Dr. Ruben A. Bartolomé

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2013 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
STSofia Torres
Sofia Torres
RBRuben A. Bartolomé
Ruben A. Bartolomé
MMMarta Mendes
Marta Mendes
RBRodrigo Barderas
Rodrigo Barderas
MFMª Jesús Fernández-Aceñero
Mª Jesús Fernández-Aceñero
JCJ. Ignacio Casal
J. Ignacio Casal
Purpose: Cancer-associated fibroblasts (CAF) are essential components of the stroma that play a critical role in cancer progression. This study aimed to identify novel CAFs markers that might contribute to the invasion and the prognosis of colorectal cancer. Experimental Design: The azoxymethane/dextran sodium sulfate mouse model of sporadic colon cancer represents an adequate source for the isolation of CAFs and normal fibroblasts. By using the explants technique, we purified CAFs and normal fibroblasts from colon tissues. Whole-cell extracts and supernatants were subjected to in-depth quantitative proteomic analysis by tandem mass spectrometry. Further validations of upregulated proteins in CAFs were carried out by chemokine microarray and immunohistochemical analyses of mouse and human tissues. Results: Using a fold-change of 1.4 or more, we found 132 and 125 differentially expressed proteins in whole-cell extracts and supernatants, respectively. We found CAFs-associated proinflammatory and desmoplastic signatures. The proinflammatory signature was composed of several cytokines. Among them, CCL2 and CCL8 caused an increase in migration and invasion of colorectal cancer KM12 cells. The desmoplastic signature was composed of 30 secreted proteins. In mouse and human samples, expression of LTBP2, CDH11, OLFML3, and, particularly, FSTL1 was significantly increased in the tumoral stroma, without significant expression in the cancer epithelial cells. The combination of CALU and CDH11 stromal expression showed a significant association with disease-free survival and poor prognosis. Conclusion: We have identified LTBP2, CDH11, OLFML3, and FSTL1 as selective biomarkers of cancer stroma, and CALU and CDH11 as candidate stromal biomarkers of prognostic significance in colon cancer. Clin Cancer Res; 19(21); 6006–19. ©2013 AACR.

31 May 2012 in Cancer Research
Verified
Journal Article
Closed access
PDF file
RBRodrigo Barderas
Rodrigo Barderas
RBRuben A. Bartolomé
Ruben A. Bartolomé
MFMª Jesús Fernández-Aceñero
Mª Jesús Fernández-Aceñero
STSofia Torres
Sofia Torres
JCJ. Ignacio Casal
J. Ignacio Casal
Autocrine secretion of cytokines by metastatic colorectal cancer cells and their role during invasion and liver homing has been poorly characterized. In this study, we used cytokine arrays to analyze the secretomes of poorly and highly metastatic colorectal cancer cells. Compared with poorly metastatic cancer cells, highly metastatic cells expressed increased levels of the immunosuppressive cytokines interleukin (IL)-4 and IL-13 in addition to increased surface expression of the high affinity IL-13 receptor IL-13Rα2, suggesting that IL-13Rα2 mediates IL-13 effects in colorectal cancer cells. Silencing of IL-13Rα2 in highly metastatic cells led to a decrease in adhesion capacity in vitro and a reduction in liver homing and increased survival in vivo, revealing a role for this receptor in cell adhesion, migration, invasion, and metastatic colonization. In support of this, IL-13 signaling activated the oncogenic signaling molecules phosphoinositide 3-kinase, AKT, and SRC in highly metastatic cells. Clinically, high expression of IL-13Rα2 was associated with later stages of disease progression and poor outcome in patients with colorectal cancer. Our findings therefore support a critical role for IL-13Rα2 expression in colon cancer invasion and metastasis. Cancer Res; 72(11); 2780–90. ©2012 AACR.

1 October 2009 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
AEAna Estecha
Ana Estecha
LSLorena SánChez-Martín
Lorena SánChez-Martín
APAmaya Puig-KrögEr
Amaya Puig-KrögEr
RBRuben A. Bartolomé
Ruben A. Bartolomé
JTJoaquín Teixidó
Joaquín Teixidó
PSPaloma Sanchez-Mateos
Paloma Sanchez-Mateos
Tumour cell dissemination through corporal fluids (blood, lymph and body cavity fluids) is a distinctive feature of the metastatic process. Tumour cell transition from fluid to adhesive conditions involves an early polarization event and major rearrangements of the submembrane cytoskeleton that remain poorly understood. As regulation of cortical actin-membrane binding might be important in this process, we investigated the role of ezrin and moesin, which are key crosslinking proteins of the ERM (ezrin, radixin, moesin) family. We used short interfering RNA (siRNA) to show that moesin is crucial for invasion by melanoma cells in 3D matrices and in early lung colonization. Using live imaging, we show that following initial adhesion to the endothelium or 3D matrices, moesin is redistributed away from the region of adhesion, thereby generating a polarized cortex: a stable cortical actin dome enriched in moesin and an invasive membrane domain full of blebs. Using Lifeact-GFP, a 17-amino-acid peptide that binds F-actin, we show the initial symmetry breaking of cortical actin cytoskeleton during early attachment of round cells. We also demonstrated that ezrin and moesin are differentially distributed during initial invasion of 3D matrices, and, specifically, that moesin controls adhesion-dependent activation of Rho and subsequent myosin II contractility. Our results reveal that polarized moesin plays a role in orienting Rho activation, myosin II contractility, and cortical actin stability, which is crucial for driving directional vertical migration instead of superficial spreading on the fluid-to-solid tissue interface. We propose that this mechanism of cortical polarization could sustain extravasation of fluid-borne tumour cells during the process of metastasis.

22 April 2013 in Oncogene
Verified
Journal Article
Closed access
RBRuben A. Bartolomé
Ruben A. Bartolomé
RBRodrigo Barderas
Rodrigo Barderas
STS Torres
S Torres
MFMª Jesús Fernández-Aceñero
Mª Jesús Fernández-Aceñero
MMMarta Mendes
Marta Mendes
JCJ. Ignacio Casal
J. Ignacio Casal

1 January 2010 in Developmental Cell
Verified
Journal Article
Closed access
PGPilar Gonzalo
Pilar Gonzalo
MGMarta C. Guadamillas
Marta C. Guadamillas
MHMaría Victoria Hernández-Riquer
María Victoria Hernández-Riquer
ÁPÁngela Pollán
Ángela Pollán
AGAraceli Grande-García
Araceli Grande-García
AAAlicia G. Arroyo
Alicia G. Arroyo

3 September 2010 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
IFIsrael S. Fernández
Israel S. Fernández
AYAkio Yamashita
Akio Yamashita
EAErnesto Arias-Palomo
Ernesto Arias-Palomo
YBYumi Bamba
Yumi Bamba
RBRuben A. Bartolomé
Ruben A. Bartolomé
ÓLÓscar Llorca
Óscar Llorca
SMG-9 is part of a protein kinase complex, SMG1C, which consists of the SMG-1 kinase, SMG-8 and SMG-9. SMG1C mediated phosphorylation of Upf1 triggers nonsense-mediated mRNA decay (NMD), a eukaryotic surveillance pathway that detects and targets for degradation mRNAs harboring premature translation termination codons. Here, we have characterized SMG-9, showing that it comprises an N-terminal 180 residue intrinsically disordered region (IDR) followed by a well-folded C-terminal domain. Both domains are required for SMG-1 binding and the integrity of the SMG1C complex, whereas the C-terminus is sufficient to interact with SMG-8. In addition, we have found that SMG-9 assembles in vivo into SMG-9:SMG-9 and, most likely, SMG-8:SMG-9 complexes that are not constituents of SMG1C. SMG-9 self-association is driven by interactions between the C-terminal domains and surprisingly, some SMG-9 oligomers are completely devoid of SMG-1 and SMG-8. We propose that SMG-9 has biological functions beyond SMG1C, as part of distinct SMG-9-containing complexes. Some of these complexes may function as intermediates potentially regulating SMG1C assembly, tuning the activity of SMG-1 with the NMD machinery. The structural malleability of IDRs could facilitate the transit of SMG-9 through several macromolecular complexes.